Michael E. Talkowski,Sureni V. Mullegama,Jill A. Rosenfeld,W. M. van Bon,Yiping Shen,Elena A. Repnikova,Julie Gastier-Foster,Devon Lamb Thrush,Sekar Kathiresan,Douglas M. Ruderfer,Colby Chiang,Carrie Hanscom,Carl Ernst,Amelia M. Lindgren,Cynthia C. Morton,Yu An,Caroline Astbury,Louise A. Brueton,Klaske D. Lichtenbelt,Lesley C. Ades,Marco Fichera,Corrado Romano,Jeffrey W. Innis,Charles A. Williams,Dennis Bartholomew,Margot I. Van Allen,Aditi Parikh,Lilei Zhang,Bai-Lin Wu,Robert E. Pyatt,Stuart Schwartz,Lisa G. Shaffer,Bert B. A. de Vries,James F. Gusella,Sarah H. Elsea

Abstract:Persons with neurodevelopmental disorders or autism spectrum disorder (ASD) often harbor chromosomal microdeletions, yet the individual genetic contributors within these regions have not been systematically evaluated. We established a consortium of clinical diagnostic and research laboratories to accumulate a large cohort with genetic alterations of chromosomal region 2q23.1 and acquired 65 subjects with microdeletion or translocation. We sequenced translocation breakpoints; aligned microdeletions to determine the critical region; assessed effects on mRNA expression; and examined medical records, photos, and clinical evaluations. We identified a single gene, methyl-CpG-binding domain 5 (MBD5), as the only locus that defined the critical region. Partial or complete deletion of MBD5 was associated with haploinsufficiency of mRNA expression, intellectual disability, epilepsy, and autistic features. Fourteen alterations, including partial deletions of noncoding regions not typically captured or considered pathogenic by current diagnostic screening, disrupted MBD5 alone. Expression profiles and clinical characteristics were largely indistinguishable between MBD5-specific alteration and deletion of the entire 2q23.1 interval. No copy-number alterations of MBD5 were observed in 7878 controls, suggesting MBD5 alterations are highly penetrant. We surveyed MBD5 coding variations among 747 ASD subjects compared to 2043 non-ASD subjects analyzed by whole-exome sequencing and detected an association with a highly conserved methyl-CpG-binding domain missense variant, p.79Gly>Glu (c.236G>A) (p = 0.012). These results suggest that genetic alterations of MBD5 cause features of 2q23.1 microdeletion syndrome and that this epigenetic regulator significantly contributes to ASD risk, warranting further consideration in research and clinical diagnostic screening and highlighting the importance of chromatin remodeling in the etiology of these complex disorders.

5q14.3 Deletion Manifesting as Mitochondrial Disease and Autism: Case Report

Chromosome Subtelomere Rearrangement in Children with Autism: a Fluorescence in Situ Hybridization Study

Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders.

Assessment of 2q23.1 Microdeletion Syndrome Implicates MBD5 As a Single Causal Locus of Intellectual Disability, Epilepsy, and Autism Spectrum Disorder

Microdeletion 5q14.3 and anomalies of brain development

Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders

Case report: Familial case with autism spectrum and bipolar disorder showing a 20q11.21 microduplication including TM9SF4

Combination of 15q24 Microdeletion Syndrome and Metabolic Imbalance in a Patient with Atypical Autism

Phenotypic and Molecular Convergence of 2q23.1 Deletion Syndrome with Other Neurodevelopmental Syndromes Associated with Autism Spectrum Disorder

De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum

Special clinical entity with 15q26 deletion: a novel case report

Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain

Microdeletion of 12q24.31: Report of a girl with intellectual disability, stereotypies, seizures and facial dysmorphisms

Early Diagnosis of the Chromosomal Deletion 5q14.2-q21.3 in a Preterm Newborn: Case Report

Case Report: Congenital Brain Dysplasia, Developmental Delay and Intellectual Disability in a Patient With a 7q35-7q36.3 Deletion

Elevated Mitochondrial DNA Copy Number in Peripheral Blood Cells is Associated with Childhood Autism

A Comprehensive and Clinical Review of Distal Deletion Syndrome of Chromosome 5q14.3

The MEF2C-Related and 5q14.3q15 Microdeletion Syndrome

Phenotypic and molecular characterization of 19q12q13.1 deletions: A report of five patients

[A Case of 10p15.3 Microdeletion Syndrome Detected by Whole Exome Sequencing].

Cleft Lip Palate in a Patient with 5q14.3 Deletion Syndrome: A Possible Unreported Feature?